Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-017382)

Filing Details

Accession Number:: 0001179110-13-017382
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-04 13:20:39
Reporting Period:: 2013-12-02

Filing Date:: 2013-12-04
Accepted Time:: 2013-12-04 13:20:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274792	Merrimack Pharmaceuticals Inc	MACK	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1345709	E Sarah Nash	C/O Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-02	47,000	$4.17	976,494	No	4	P	Direct
Common Stock	Acquisiton	2013-12-03	500	$4.35	976,994	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.162 to $4.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.